Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Walgreens #05814

Neither a doctor nor a teaching hospital

Research payments

$7,835

11 payments

Through program year 2025, Walgreens #05814 is reported as receiving $7,835 in research payments, across 11 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $7,835 11

Breakdown

Who paid Research payments · program year 2025
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $6,677 1 payment
  2. Boehringer Ingelheim International GmbH $767 9 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $392 1 payment
Studies the money was for Research payments · program year 2025
  1. A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease. $7,835 11 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record